Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$25,019,172,732
+$5,725,132,609 QoQ
Shares Held
20,859,217
-0.6% QoQ
Ownership
2.22%
of shares outstanding
% of Portfolio
1.13%
of 13F equity value
Holder Rank
#8
of 4,587 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VANGUARD PORTFOLIO MANAGEMENT LLC holds $79,321,305,947 across 11 Drug Manufacturers - General names. LLY ranks #1 (31.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
20,859,217 | $25,019,172,732 | |
| 2 | JNJ |
Johnson & Johnson
|
64,370,816 | $16,348,256,139 | |
| 3 | ABBV |
AbbVie Inc.
|
48,477,996 | $12,199,002,913 | |
| 4 | MRK |
Merck & Co., Inc.
|
67,738,969 | $8,704,457,516 | |
| 5 | AMGN |
Amgen Inc
|
14,853,366 | $5,378,700,895 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
35,316,168 | $4,461,844,665 | |
| 7 | PFE |
Pfizer Inc
|
119,235,030 | $2,871,179,522 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
46,873,015 | $2,700,823,124 |
All Filings in LLY
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,019,172,732 | 20,859,217 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $19,294,040,123 | 20,977,027 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||